We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

174 hedge funds and large institutions have $2.14B invested in NEVRO CORP. in 2016 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 83 increasing their positions, 53 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more call options, than puts

Call options by funds: $19.4M | Put options by funds: $10.7M

57% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 53

9% less funds holding

Funds holding: 192174 (-18)

29% less capital invested

Capital invested by funds: $3.02B → $2.14B (-$880M)

35% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 43

63% less funds holding in top 10

Funds holding in top 10: 83 (-5)

Holders
174
Holders Change
-18
Holders Change %
-9.38%
% of All Funds
4.34%
Holding in Top 10
3
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-62.5%
% of All Funds
0.07%
New
28
Increased
83
Reduced
53
Closed
43
Calls
$19.4M
Puts
$10.7M
Net Calls
+$8.63M
Net Calls Change
+$12.4M

NVRO Hedge Fund Activity: Q4 2016 in Review

174 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q4 2016, worth a combined $2.14B — down 29% from $3.02B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of NVRO and 28 opened new positions — a net loss of 15 holders — while 53 trimmed existing stakes and 83 added.

The largest buyer was Goldman Sachs, adding an estimated $59.1M. The largest seller was Fidelity Investments, cutting an estimated $121M.

  • 174 institutional investors held NEVRO CORP. (NVRO) as of Q4 2016, down from 192 in Q3 2016.
  • Funds reported $2.14B of NEVRO CORP. stock for Q4 2016, down 29% quarter-over-quarter.
  • 28 funds opened new NEVRO CORP. positions in Q4 2016 and 43 closed out, a net change of -15 holders.
  • The largest NEVRO CORP. buyer in Q4 2016 was Goldman Sachs, an estimated $59.1M added.
  • The largest NEVRO CORP. seller in Q4 2016 was Fidelity Investments, an estimated $121M sold.

Based on aggregated 13F filings for Q4 2016.